CD-20 mabs (Rituximab)

 

We have ELISA kits to detect antibodies to Rituximab (Human Anti-Rituximab Antibodies) in patients receiving long-term treatments.

 


.....Read More.

 

Catalog# Product Description Product Type Size
200-200-HAH Human Anti-Human IgG (HAHA) ELISA kit, 96 tests Kit 1 kit
200-205-HAM Human Anti-Mouse IgG (HAMA) ELISA kit, 96 tests Kit 1 kit
200-210-RAG Rituximab/Rituxan/Anti-CD20 (Active) ELISA Kit (Human/mouse/rat),96 tests Kit 1 kit
200-245-HAM Human Anti-Rituximab/Rituxan (HADA/HAMA) IgG ELISA kit for human, 96 tests Kit 1 kit
200-300-ADG Humira/Adalimumab (Human Anti-TNF-alpha) ELISA Kit for dog, 96 tests Kit 1 kit
200-310-AHG Humira/Adalimumab (Human Anti-TNF-alpha) ELISA Kit for human, 96 tests Kit 1 kit
200-320-ADG Human Anti-Humira/Adalimumab (Human Anti-TNF-alpha) IgG ELISA Kit, 96 tests Kit 1 kit
200-320-AHG Human Anti-Humira/Adalimumab (Human Anti-TNF-alpha) ELISA Kit for human, 96 tests Kit 1 kit
200-330-TNF Human TNF-alpha ELISA Kit, 96 tests Kit 1 kit
CD20-141-R Recombinant Human CD20/MS4A1-mFC fusion Protein (141-184, 44-aa, ECD, rituximab-binding peptide) Recombinant protein 20 ug
CD20-142-P Human CD20/MS4A1 linear peptide (142-184, 43-aa, extracellular domain) rituximab-binding peptide, >95% pure peptide 100 ug
CD20-145-R Recombinant (HEK cells) purified human CD20/MS4A1 (213-297 aa) his tag Protein Recombinant protein 20 ug
CD20-146-R Recombinant (HEK cells) human CD20/MS4A1 (141-184 aa) hFc- fusion Protein Recombinant protein 10 ug
CD20-147-R Recombinant (HEK cells) purified Ferrret CD20/MS4A1 (213-297 aa) his tag Protein Recombinant protein 10 ug
CD20-165-P human CD20/MS4A1 linear peptide (165-184, 20-aa, extracellular domain) broad reactivity with CD20-specific antibodies peptide 100 ug
CD20-1731-P Human CD20/MS4A1 peptide (Acetyl-cPYaNPSLc, 9-aa, Cyclic Cys1-Cys9); contains ANPS motif and reactivity with Rituximab cyclic peptide 100 ug
CD20-1732-P Human CD20/MS4A1 cylcic peptide (Acetyl-cWAANPSMAc, 11 aa, Cys1-Cys11); contains the ANPS motif and avidity for rituximab cyclic peptide 100 ug
CD20-1733-P Human CD20/MS4A1 cyclic peptide (Acetyl-cPYsNPSLc; 9aa, Cys1-Cys9; contains NPS motif and react with rituximab cyclic peptide 100 ug
CD20-182-P Human CD20/MS4A1 linear peptide (CWWEWTIGC, 9-aa) contains motif WEWTI of human CD-20 for rtiuximab peptide 100 ug
CD20-21-M Monoclonal Anti-Human CD20/MS4A1 peptide (EC-domain, rituximab binding) ascites Antibodies 100 ul
CD20-22-A Anti-Human CD20/MS4A1 peptide (EC-domain, rituximab binding domain) IgG, aff pure Antibodies 100 ul
CD20-22-P Anti-Human CD20/MS4A1 control/blocking peptide (EC-domain, rituximab binding domain) Antibodies 100 ug
CD20-23-M Humanized (chimeric) Anti-Human CD20/MS4A1 IgG (rituximab biosimilar), pure Antibodies 100 ul
CD20-RP1L-P CD20/MS4A1 linear peptide (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) and reacts with rituximab peptide 100 ug
CD20-RP5L-P CD20/MS4A1 linear peptide (QDKLTQWPKWLEg, 13-aa) contains WPXWLE motif and reacts with rituximab peptide 100 ug
CD20F-100 Anti-Human CD20-FITC conjugate Antibodies 100 Tests
CD20P-100 Anti-Human CD20-PE conjugate Antibodies 100 Tests
CD20PC-100 Anti-Human CD20-PE-Cy5-conjugate Antibodies 100 Tests
CD20UL-100 Anti-Human CD20 IgG, Unlabeled Antibodies 100 ug
RP-340 Recombinant Anti-Human CD20 Antibody IgG Antibodies 50 ug
RP1L-P CD20/MS4A1 linear peptide (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) and reacts with rituximab peptide 100 ug
RP5L-P CD20/MS4A1 linear peptide (QDKLTQWPKWLEg, 13-aa) contains WPXWLE motif and reacts with rituximab peptide 100 ug